Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker ACXP
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 13, 2026 | ACXP Acurx Pharmaceuticals, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 29, 2026 | ACXP Acurx Pharmaceuticals, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Oct 16, 2026 | ACXP Acurx Pharmaceuticals, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Apr 16, 2026 | ACXP Acurx Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 16, 2026 | ACXP Acurx Pharmaceuticals, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Apr 16, 2026 | ACXP Acurx Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 9, 2026 | ACXP Acurx Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 9, 2026 | ACXP Acurx Pharmaceuticals, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 22, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Sep 19, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jul 31, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 31, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Jul 31, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Jul 17, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 20, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 20, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jun 20, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 13, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 8, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| May 8, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 28, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Mar 18, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 10, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 10, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Mar 10, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 26, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Jan 7, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 7, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jan 7, 2025 | ACXP Acurx Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 13, 2024 | ACXP Acurx Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
30 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:45 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances